Minerva Neurosciences NERV
NASDAQ NERV
$2.48 -0.15 (-5.51%)
As of: Nov 10, 2026 · 1:34 PM EST

Minerva Neurosciences (NERV) Acquisitions (2014)

Updated

Minerva Neurosciences' Acquisitions came in at -$1.17 million for FY2014, compared with -$631,478 in FY2013.

Analysis

Minerva Neurosciences (NERV) Acquisitions (2014) Analysis & Trends

  • Per Business Quant, earlier years put Acquisitions at -$631,478 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -17.15 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 10.59 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Minerva Neurosciences 121.62 Mn -126.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -1.17 Mn
API Access

Minerva Neurosciences Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=NERV&period=max&api_key=YOUR_API_KEY